Magnesium Sulfate vs Placebo for Placental Abruption

• Status: Completed
• Trial end date: 2017-11-01
• Target enrollment: 0
• Participant gender: Female

Summary

To evaluate the safety and efficacy of magnesium sulfate for preterm suspected abruption.

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Stanford University
• Collaborator: Santa Clara Valley Medical Center
• Treatments: Magnesium Sulfate

Criteria

Inclusion Criteria:

• vaginal bleeding and contractions consistent with suspected placental abruption between 24 and 34 weeks gestation.

Exclusion Criteria:

• preterm labor, severe bleeding necessitating immediate delivery, maternal coagulopathy, fetal distress